Humanized Liver Mice Model Market is expected to reach US$ 142.33 Mn. at a CAGR of 6.12% during the forecast period 2030.Humanized Liver Mice Model Market Overview
Humanized mouse models have emerged as a promising alternative to traditional animal models.The human liver serves as the reservoir for several important pathogens, which are responsible for more than half-a-billion infections and between 2.5 and 4.5 million deaths annually. The report covers the current estimate and forecast for Market on a global and regional level. The report provides an in-depth analysis of the Humanized Liver Mice Model Market for the period 2024 – 2030, wherein 2023 is the base year and the period from 2024 to 2030 is the forecast period. Data for 2018- 2023 has been included as historical information. The study provides a detail perspective on market growth, throughout the above forecast period in terms of revenue estimates (in US$ Mn), across different geographies, which includes North America (NA), Europe (EU), Asia Pacific (APAC), Middle East & Africa (MEA) and South America.To Know About The Research Methodology :- Request Free Sample Report The report provides qualitative and quantitative insights on the Humanized Liver Mice Model industry trends and detail analysis of market size and growth rate of all segment in the market. The global Humanized Liver Mice Model market is segmented by Application, and Region. Key Players Operated in Global Market are The Jackson Laboratory, Crown Bioscience Inc., Charles River Laboratories International Inc., Taconic Biosciences Inc., Ingenious Targeting Laboratory Inc., Trans Genic Inc. Ltd., GenOway, Creative Animodel, Horizon Discovery Group plc., Hera BioLabs, PhoenixBio Group, Beijing Vitalstar Biotechnology Co. Ltd., Yecuris Corporation.
Humanized Liver Mice Model Market Dynamics
Increased number of government funds for liver-based disease therapies have increased numbers in research and development activities which will boosting the global market in the forecast period. Advances in the generation and maintenance of humanized mice liver have made them more robust tools and have stimulated interest in using them as models for answering additional liver-specific questions.Many new genomic editing therapies under development, where humanized liver mice offer a unique testing environment for genomic editing therapy delivery methods, shows significant opportunities for global market.Humanized Liver Mice Model Market Segment Analysis
Pharmacokinetic Studies segment is expected to grow at a CAGR of xx% in the forecast period. Humanized transgenic mice are valuable animal models in understanding the significance of specific human drug-metabolizing enzymes in drug clearance and pharmacokinetics, as well as in predicting potential drug-drug interactions and chemical toxicity in humans. Human liver mice have been employed for preclinical evaluation of efficacy, toxicology, and pharmacokinetic profiles of small molecule drug candidates and biologicals, including antibodies targeting host and pathogen components. Preclinical evaluation of vaccine potency in mice engrafted with human tissues efficiently supporting various pathologies, and safety, efficacy, and pharmacokinetics studies of drugs and therapeutic biologicals. Drug metabolism profiles indicate that human liver mice models shows the useful results for predicting human drug interactions, as well as endogenous enzyme induction and inhibition, all of these reasons gives the growth opportunity for global humanized liver mice model marketin drug development. For example, mice with a human immune system and supplementary human lung tissue could model tuberculosis or cytomegalovirus (CMV) pathogenesis.Humanized Liver Mice Model Market Regional Insights
Europe is leading in the global market and maintain its steady position in the forecast period. High research facilities and implementation of research facilities in research organisations, especially in the life science is projected to grow the global market. Advances in genetic studies and large number of ongoing research on the humanized liver mice model, grow the global market in Europe economies. Development of new genetically engineered human liver model with advance technology is a key development, which make positive impact on global humanized liver mice model.Humanized Liver Mice Model Market Scope: Inquire before buying
Global Humanized Liver Mice Model Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 93.91 Mn. Forecast Period 2024 to 2030 CAGR: 6.12% Market Size in 2030: US $ 142.33 Mn. Segments Covered: by Application Pharmacokinetics Studies In-vivo Liver Toxicity Testing Drug Metabolism Studies Others Humanized Liver Mice Model Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe) Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina, Columbia and Rest of South America)Humanized Liver Mice Model Market, Key Players are
1. The Jackson Laboratory 2. Crown Bioscience Inc. 3. Charles River Laboratories International Inc. 4. Taconic Biosciences Inc. 5. Ingenious Targeting Laboratory Inc. 6. Trans Genic Inc. Ltd. 7. GenOway 8. Creative Animodel 9. Horizon Discovery Group plc. 10. Hera BioLabs 11. PhoenixBio Group 12. Beijing Vitalstar Biotechnology Co. Ltd. 13. Yecuris Corporation Frequently Asked Questions: 1. Which region has the largest share in Global Market? Ans: Europe region holds the highest share in 2023. 2. What is the growth rate of Global Market? Ans: The Global Market is growing at a CAGR of 6.12% during forecasting period 2024-2030. 3. What is scope of the Global Humanized Liver Mice market report? Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global market? Ans: The important key players in the Global Market are – The Jackson Laboratory, Crown Bioscience Inc., Charles River Laboratories International Inc., Taconic Biosciences Inc., Ingenious Targeting Laboratory Inc., Trans Genic Inc. Ltd., GenOway, Creative Animodel, Horizon Discovery Group plc., Hera BioLabs, PhoenixBio Group, Beijing Vitalstar Biotechnology Co. Ltd., Yecuris Corporation 5. What is the study period of this market? Ans: The Global Market is studied from 2023 to 2030.
Global Humanized Liver Mice Model Market
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Humanized Liver Mice Model Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2021 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Humanized Liver Mice Model Market 3.4. Geographical Snapshot of the Humanized Liver Mice Model Market, By Manufacturer share 4. Global Humanized Liver Mice Model Market Overview, 2023-2030 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Humanized Liver Mice Model Market 5. Supply Side and Demand Side Indicators 6. Global Humanized Liver Mice Model Market Analysis and Forecast, 2023-2030 6.1. Global Humanized Liver Mice Model Market Size & Y-o-Y Growth Analysis. 7. Global Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 7.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 7.1.1. Pharmacokinetics Studies 7.1.2. In-vivo Liver Toxicity Testing 7.1.3. Drug Metabolism Studies 7.1.4. Others 8. Global Humanized Liver Mice Model Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2023-2030 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 9.1. Market Size (Value) Estimates & Forecast By End users, 2023-2030 9.1.1. Pharmacokinetics Studies 9.1.2. In-vivo Liver Toxicity Testing 9.1.3. Drug Metabolism Studies 9.1.4. Others 10. North America Humanized Liver Mice Model Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 11.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 12. Canada Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 12.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 13. Mexico Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 13.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 14. Europe Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 14.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 15. Europe Humanized Liver Mice Model Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 16.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 17. France Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 17.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 18. Germany Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 18.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 19. Italy Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 19.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 20. Spain Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 20.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 21. Sweden Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 21.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 22. CIS Countries Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 22.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 23. Rest of Europe Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 23.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 24. Asia Pacific Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 24.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 25. Asia Pacific Humanized Liver Mice Model Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2023-2030 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 26.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 27. India Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 27.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 28. Japan Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 28.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 29. South Korea Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 29.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 30. Australia Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 30.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 31. ASEAN Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 31.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 32. Rest of Asia Pacific Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 32.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 33. Middle East Africa Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 33.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 34. Middle East Africa Humanized Liver Mice Model Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2023-2030 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 35.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 36. GCC Countries Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 36.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 37. Egypt Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 37.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 38. Nigeria Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 38.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 39. Rest of ME&A Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 39.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 40. South America Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 40.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 41. South America Humanized Liver Mice Model Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2023-2030 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 42.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 43. Argentina Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 43.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 44. Rest of South America Humanized Liver Mice Model Market Analysis and Forecasts, 2023-2030 44.1. Market Size (Value) Estimates & Forecast By Application, 2023-2030 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Humanized Liver Mice Model Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of key players by price, presence, market share, Product Types and R&D investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Product Type 45.2.3.2. M&A Key Players, Forward Integration and Backward Integration 45.3. Company Profile - The Jackson Laboratory 45.3.1. Company Overview 45.3.2. Financial Overview 45.3.3. Geographic Footprint 45.3.4. Product Portfolio 45.3.5. Business Strategy 45.3.6. Recent Developments 45.4. Crown Bioscience Inc. 45.5. Charles River Laboratories International Inc. 45.6. Taconic Biosciences Inc. 45.7. Ingenious Targeting Laboratory Inc. 45.8. Trans Genic Inc. Ltd. 45.9. GenOway 45.10. Creative Animodel 45.11. Horizon Discovery Group plc. 45.12. Hera BioLabs 45.13. PhoenixBio Group 45.14. Beijing Vitalstar Biotechnology Co. Ltd. 45.15. Yecuris Corporation 46. Primary Key Insights